Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Other Affiliated Sites

Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL

Serving Customers with Cutting-Edge Technology

and Excellent Delivery Capabilities

CDMO Services

Hepalink operates its fast-growing CDMO business through two of its wholly-owned subsidiaries, namely Cytovance and SPL, to seize growth opportunities in the global biopharmaceutical industry while supporting the clinical development of the company’s innovative drugs.

Cytovance Biologics, Inc.

A CDMO platform providing end-to-end services related to mammalian cell culture, microbials, cell and gene therapies, and mRNA products.

SPL Acquisition Corp.

A CDMO platform specializes in the development and manufacturing of naturally derived pharmaceuticals.

Cytovance Biologics, Inc.

In 2015, Hepalink completed its acquisition of Cytovance Biologics, a leading biotechnology company specializes in the development and manufacturing of large molecule biologics.

-Located in the state of Oklahoma, United Stated
-Over 300 employees
-Specializes in recombinant and naturally derived large molecules and gene therapy products
-Developed over 170 large molecule biologic products targeting 15 therapeutic areas
-In 2020, began manufacturing key enzymes to support the mass production of mRNA COVID-19 vaccines

Visit Cytovance’s official site

SPL Acquisition Corp.

In 2014, Hepalink completed its acquisition of SPL, the largest manufacturer of heparin sodium APIs in the U.S.

-Located in the state of Wisconcin, United States
-Specializes in the cGMP production of biopharmaceutical products, and is one of the world’s largest suppliers of heparin sodium, pancreatin, and pancrelipase APIs.
-Provides CDMO services in Current Good Manufacturing Practices (cGMP)-compliant manufacturing of heparin derivatives, natural products extraction, fermentation and purification.

Visit SPL’s official site

Legal Statement · Environmental Disclosure

尊龙凯时(中国)登录入口